Discusses medical care for athletes with hemophilia. Preparticipation physical examination; Acute-injury management; Return-to-play guidelines; Education ... Fiala,Kelly,A.,... - 《Athletic Therapy Today》 被引量: 0发表: 2004年 The diagnosis and nonoperative treatment of shoulder injuries in athle...
THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never igno...
BACKGROUND: Recombinant activated Factor VII (rFVIIa) is a prohemostatic agent used for treatment of hemophilia patients with inhibiting antibodies. It has... FF Berkhof,JCJ Eikenboom - 《Transfusion》 被引量: 31发表: 2010年 Using Task Analysis to Improve the Requirements Elicitation in Health In...
HEMOPHILIACSMEDICAL care costsEMICIZUMABJAPANESE peopleHEMOPHILIA treatmentBLOOD coagulation factor VIIITreatment for haemophilia A has expanded from plasma-derived factor VIII (pdFVIII) and standard half-life (SHL) recombinant FVIII (rFVIII) to extended half-life (EHL) rFVIII and non-factor products...
Takeda's booth also features five innovative products for hemophilia, including a gene therapy that provides diverse treatment options for patients with various types of hemophilia and distinct treatment requirements. Liu Yan, head of the hemophilia and rare disease business branch at Takeda China, sai...
Yesterday News for Health Professionals FDA Approves Zepbound for Sleep Apnea in Patients With Obesity MONDAY, Dec. 23, 2024 -- The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of... Yesterday News for Health Pr...
Farlex Partner Medical Dictionary © Farlex 2012 Want to thank TFD for its existence?Tell a friend about us, add a link to this page, or visitthe webmaster's page for free fun content. Link to this page: Facebook Twitter Full browser?
Hemophilia is one of the rare diseases, and a medical device program (IT program to support treatment) for providing personalized treatment based on standardized treatment for hemophilia, myPKFiT®, has been developed. It is known that the pharmacokinetics (PK; Pharmacokinetics) of the coagulation...
Wayne, MD, director of the Children's Center for Cancer and Blood Diseases, "This is a breakthrough for individuals with hemophilia A who no longer respond to conventional clotting therapies. The standard treatment for patients with hemophilia A and inhibitors has been to use medications called ...
Organization issues clinical practice guideline for the treatment of hemophilia In a clinical practice guideline issued by the International Society on Thrombosis and Haemostasis and published online June 13 in the Journal of Thrombosis and Haemostasis, recommendations are presented for the treatment ......